Biotech News
Related news
RXRXRecursion2026-11-02 21:30 EST
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
RXRXRecursion2026-11-02 21:05 EST
Recursion Appoints Fred Hassan as Chair of the Board
MDXGMiMedx2026-11-06 13:00 EST
MIMEDX to Participate in Upcoming Investor Conferences
IBIOIbio Inc2026-11-02 21:30 EST
iBio to Participate in Upcoming Investor Conferences
CHRSCoherus BioSciences, Inc.2026-10-27 13:30 EST
Coherus to Participate in Upcoming Investor Conferences
ENTXEntera Bio2026-08-27 13:44 EST
Correction: Entera to Participate in Upcoming Fall Investor Conferences
ENTXEntera Bio2026-08-27 12:00 EST
Entera to Participate in Upcoming Fall Investor Conferences
IBIOIbio Inc2026-06-02 20:01 EST
iBio to Participate in Upcoming Healthcare Investor Conferences
PHARPharming Group2026-09-09 06:00 EST
Pharming Group to participate in September investor conferences
APGEApogee Therapeutics2026-05-28 20:01 EST
Apogee Therapeutics to Participate in Upcoming June Conferences
Recursion
AI-Native Drug Discovery Recursion is a clinical-stage TechBio company using an integrated discovery and development platform to generate medicines across oncology, rare disease, neuroscience and immunology. The Recursion OS combines proprietary multimodal biological and chemical data, purpose-built AI models and experimental...
Recent company news
RXRXRecursion2026-11-11 13:00 EST
Recursion to Participate in Upcoming Investor Conferences
RXRXRecursion2026-11-02 21:30 EST
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
RXRXRecursion2026-11-02 21:25 EST
New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps
RXRXRecursion2026-11-02 21:05 EST
Recursion Appoints Fred Hassan as Chair of the Board
RXRXRecursion2026-10-26 20:05 EST
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
Stock data
- Close
- 2.72 USD
- Market cap
- 1.92B USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
